As of 2026-06-16, the Fair Value of Immunic Inc (IMUX) is -38.28 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 13.86 USD, the upside of Immunic Inc is -376.22%.
With the market price of 13.86 USD and our fair value calculation, Immunic Inc (IMUX) is not a good investment. Investing in IMUX stocks now will result in a potential loss of 376.22%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -92.95 | -120.41 | -93.61 | -100.51 | -97.17 | -100.93 |
| YoY growth | -111.15% | -29.54% | 22.26% | -7.37% | 3.32% | -24.50% |
| Market Cap (mil) | 188.77 |
| P/E | |
| Forward P/E |
| EPS | -7.66 |
| Avg earnings growth rate | -24.50% |
| TTM earnings | -104.29 |